Background Both antibody and cell-mediated immune responses are involved in the
defence against influenza. In Wegener's granulomatosis (WG), antibody responses to …

Objectives: Wegener's granulomatosis (WG) is a systemic vasculitis characterised by
relapsing and remitting disease activity. Immunosuppressive drugs are used to control …

Objective To determine whether a specific cytokine pattern (type 1 [Th1] or type 2 [Th2])
predominates in Wegener's granulomatosis (WG), by evaluating interferon‐γ (IFNγ) and …

Background: Current therapies for antineutrophil cytoplasmic antibody (ANCA)-associated
vasculitis are limited by toxicity. Objective: To compare pulse cyclophosphamide with daily …

Wegener's granulomatosis (WG) is a chronic inflammatory autoimmune disease of as-yet-
unknown etiology characterized by necrotizing granulomatous lesions, glomerulonephritis …

Several lines of evidence argue in favour of an involvement of T cells in the pathogenesis of
Wegener's granulomatosis (WG). These include the presence of highly specific IgG …

OBJECTIVE Wegener's granulomatosis (WG) is an inflammatory disorder characterised by
granulomatous inflammation, vasculitis, and necrotising vasculitis and is strongly associated …

Objective: To characterise major infectious complications and analyse potential risk factors
in patients with Wegener granulomatosis (WG). Methods: Data from 113 patients with WG …

We gene r's granulomatosis (WG) is characterized by granulomatous inflammation and
systemic vasculitis with a predilection for the lungs and kidneys. In most patients WG begins …

METHODS AND RESULTS We treated 168 patients with RA between 1 April 2000 and 1
October 2002, 82% female, with a median disease duration of 10 years (range 1–49) …